Burkholderia cepacia complex: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 55: Line 55:
[[Category:Proteobacteria]]
[[Category:Proteobacteria]]
[[Category:Burkholderiales]]
[[Category:Burkholderiales]]
 
[[Category:Infectious Disease Project]]





Revision as of 18:14, 7 August 2015

Burkholderia cepacia complex
File:Burkholderia cepacia.jpg
Scientific classification
Kingdom: Bacteria
Phylum: Proteobacteria
Class: Beta Proteobacteria
Order: Burkholderiales
Family: Burkholderiaceae
Genus: Burkholderia
Species: B. cepacia complex
Binomial name
Burkholderia cepacia complex
(Palleroni and Holmes 1981)
Yabuuchi et al. 1993
Type species
ATCC 25416

CCUG 12691 and 13226
CFBP 2227
CIP 80.24
DSM 7288
HAMBI 1976
ICMP 5796
JCM 5964
LMG 1222
NBRC 14074
NCCB 76047
NCPPB 2993
NCTC 10743
NRRL B-14810

Synonyms

Pseudomonas cepacia Burkholder 1950
Pseudomonas multivorans Stanier et al. 1966
Pseudomonas cepacia (ex Burkholder 1950) Palleroni and Holmes 1981
Pseudomonas kingii Jonsson 1970

WikiDoc Resources for Burkholderia cepacia complex

Articles

Most recent articles on Burkholderia cepacia complex

Most cited articles on Burkholderia cepacia complex

Review articles on Burkholderia cepacia complex

Articles on Burkholderia cepacia complex in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Burkholderia cepacia complex

Images of Burkholderia cepacia complex

Photos of Burkholderia cepacia complex

Podcasts & MP3s on Burkholderia cepacia complex

Videos on Burkholderia cepacia complex

Evidence Based Medicine

Cochrane Collaboration on Burkholderia cepacia complex

Bandolier on Burkholderia cepacia complex

TRIP on Burkholderia cepacia complex

Clinical Trials

Ongoing Trials on Burkholderia cepacia complex at Clinical Trials.gov

Trial results on Burkholderia cepacia complex

Clinical Trials on Burkholderia cepacia complex at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Burkholderia cepacia complex

NICE Guidance on Burkholderia cepacia complex

NHS PRODIGY Guidance

FDA on Burkholderia cepacia complex

CDC on Burkholderia cepacia complex

Books

Books on Burkholderia cepacia complex

News

Burkholderia cepacia complex in the news

Be alerted to news on Burkholderia cepacia complex

News trends on Burkholderia cepacia complex

Commentary

Blogs on Burkholderia cepacia complex

Definitions

Definitions of Burkholderia cepacia complex

Patient Resources / Community

Patient resources on Burkholderia cepacia complex

Discussion groups on Burkholderia cepacia complex

Patient Handouts on Burkholderia cepacia complex

Directions to Hospitals Treating Burkholderia cepacia complex

Risk calculators and risk factors for Burkholderia cepacia complex

Healthcare Provider Resources

Symptoms of Burkholderia cepacia complex

Causes & Risk Factors for Burkholderia cepacia complex

Diagnostic studies for Burkholderia cepacia complex

Treatment of Burkholderia cepacia complex

Continuing Medical Education (CME)

CME Programs on Burkholderia cepacia complex

International

Burkholderia cepacia complex en Espanol

Burkholderia cepacia complex en Francais

Business

Burkholderia cepacia complex in the Marketplace

Patents on Burkholderia cepacia complex

Experimental / Informatics

List of terms related to Burkholderia cepacia complex


Burkholderia cepacia complex (BCC), or simply Burkholderia cepacia is a group of catalase-producing, non-lactose-fermenting Gram-negative bacteria composed of at least nine different species, including B. cepacia, B. multivorans, B. cenocepacia, B. vietnamiensis, B. stabilis, B. ambifaria, B. dolosa, B. anthina, and B. pyrrocinia.[1] B. cepacia is an important human pathogen which most often causes pneumonia in immunocompromised individuals with underlying lung disease (such as cystic fibrosis or chronic granulomatous disease).[2]

Pathogenesis

BCC organisms are typically found in water and soil and can survive for prolonged periods in moist environments. Person-to-person spread has been documented; as a result, many hospitals, clinics, and camps for patients with cystic fibrosis have enacted strict isolation precautions for those infected with BCC. Infected individuals are often treated in a separate area than noninfected patients to limit spread, since BCC infection can lead to a rapid decline in lung function and result in death.

Diagnosis of BCC involves isolation of bacteria from sputum cultures. BCC organisms are naturally resistant to many common antibiotics including aminoglycosides and polymyxin B.[3] The bacteria is so hardy that it has been found to persist in betadine (a common topical antiseptic).[4] Treatment typically includes multiple antibiotics and may include ceftazidime, doxycycline, piperacillin, chloramphenicol, and co-trimoxazole.[3] In April 2007 Researchers from the Schulich School of Medicine & Dentistry at The University of Western Ontario, working with a group from Edinburgh, announced they had discovered a way to kill the the organism.[5]

History

B.cepacia was discovered by Walter Burkholder in 1949 as the culprit of onion skin rot, and first described as a human pathogen in the 1950s.[6] In the 1980s, it was first recognized in individuals with cystic fibrosis, and outbreaks were associated with a 35% death rate. Burkholderia cepacia has a large genome, containing twice the amount of genetic material as E. coli.

Gallery

Anti microbial regimen

  • Burkholderia cepacia complex[8]

References

  1. Lipuma J (2005). "Update on the Burkholderia cepacia complex". Curr Opin Pulm Med. 11 (6): 528–33. PMID 16217180.
  2. Mahenthiralingam E, Urban T, Goldberg J (2005). "The multifarious, multireplicon Burkholderia cepacia complex". Nat Rev Microbiol. 3 (2): 144–56. PMID 15643431.
  3. 3.0 3.1 McGowan J (2006). "Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum". Am J Infect Control. 34 (5 Suppl 1): S29–37, discussion S64-73. PMID 16813979.
  4. Anderson R, Vess R, Panlilio A, Favero M (1990). "Prolonged survival of Pseudomonas cepacia in commercially manufactured povidone-iodine". Appl Environ Microbiol. 56 (11): 3598–600. PMID 2268166.
  5. "Key Found to Kill Cystic Fibrosis Superbug". Innovations Report. April 25 2007. Retrieved 2007-04-26. Check date values in: |date= (help)
  6. Burkholder WH (1950). "Sour skin, a bacterial rot of onion bulbs". Phytopathology. 40: 115&ndash, 7.
  7. "Public Health Image Library (PHIL)".
  8. Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.

External links


de:Burkholderia cepacia


Template:WS